Quetiapine Fumarate XR Tablets

Contract SPE2D2-23-D-0012 is a small business award issued by DLA Troop Support to Golden State Medical Supply, Inc. for the procurement of Quetiapine Fumarate XR Tablets in 50MG, 150MG, 200MG, 300MG, and 400MG dosages. The total contract value is 4,329,877.25 dollars, covering a base year and four option years from October 18, 2023, through October 17, 2028. Modification P00004 specifically exercises Option Year 1 for the period of October 18, 2024, through October 17, 2025, pursuant to FAR 52.217-9. Performance takes place in Hauppauge, New York, with delivery terms set as FOB Destination. The contract mandates strict adherence to the Drug Supply Chain Security Act for product traceability and licensing. All pharmaceutical packaging must feature unit-of-use bar code labeling conforming to GSI-128 or HIBC standards, encoding the National Drug Code, lot number, and expiration date with a print quality of ANSI/ISO/IEC grade C or better. The agreement incorporates comprehensive FAR and DFARS clauses governing business ethics, supply chain risk, and labor standards, while requiring compliance with HDMA guidelines for labeling practices.